| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.6M | +22.3% |
| Cost of Revenue | $6.9M | +15.6% |
| Gross Profit | $63.7M | +23.0% |
| R&D Expense | $49.9M | +10.9% |
| SG&A Expense | $20.1M | +14.7% |
| Operating Income | -$33.1M | -4.9% |
| Pre-tax Income | -$33.3M | -6.9% |
| Income Tax | $1.5M | -41.0% |
| Net Income | -$34.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.9M | +147.7% |
| Accounts Receivable | $19.2M | -6.9% |
| Current Assets | $82.4M | +19.3% |
| Total Assets | $115.0M | +8.4% |
| Current Liabilities | $73.2M | +23.5% |
| Total Liabilities | $129.7M | +20.8% |
| Stockholders' Equity | -$14.6M | -1131.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.7M | +1035.1% |
| Capital Expenditures | $1.4M | +328.4% |
| Investing Cash Flow | $12.0M | +1140.0% |
| Financing Cash Flow | $1.4M | +640.8% |
| Free Cash Flow | $5.3M | +612.0% |
| -3.3% |
| EPS (Basic) | -$0.82 | +4.7% |
| EPS (Diluted) | -$0.82 | +4.7% |